Top 10 CleanTech VC (Venture Capital) Funds in Italy in December 2024
A list of 10 VC (Venture Capital) funds that invest in Cleantech startups based in Italy. We rank investors based on the number of investments they made in Cleantech companies from Italy. We update this investor list every month.Top 10 CleanTech VC (Venture Capital) Funds in Italy in December 2024
Investor | CleanTech Italy investments |
---|---|
Cassa Depositi e Prestiti | 6 |
CDP Venture Capital | 4 |
Lazio Innova | 1 |
A11 Venture | 1 |
Eureka Venture | 1 |
NextEnergy Capital | 1 |
Key Capital | 1 |
Club degli Investitori | 1 |
LIFTT | 1 |
Novum Capital Partners | 1 |
The Cassa Depositi e Prestiti Group is the national promotional institution that has supported the Italian economy since 1850
Show more
Investment focus
- Health Care, Manufacturing, CleanTech
- Pre-Seed, Post-IPO Debt, Debt Financing
- Italy, Spain
Portfolio highlights
- Arxax — Arxax is a cleantech company paving the way towards a more sustainable future by revolutionizing refueling in road transport.Through our passion for a cleaner, greener world we have developed a smart network of green refueling stations powered by our proprietary suite of connected technology solutions. Our suite of products uses data signalsfrom existing IoT hardware devices such as truck telematics, sensors, Outdoor Payment Terminals and smartphones to bring access to low and zero carbon fuels at optimally located refuelling stations, competitive pricing and full refuelling visibility to our customers.
- MrCall — Un assistente digitale dedicato al tuo business, che risponde quando non puoi, raccoglie i messaggi e li trascrive in una mail, un SMS o un messaggio Whatsapp.Configurabile e attivo sul telefono in due passaggi. Senza cambiare operatore, senza installare nuovi software, senza nuovi centralini.Nessun investimento o costo di attivazionerichiesto.
- Acea — Acea operates in six business segments. The water segment collects, purchases, transports and distributes drinking water, and manages the sewerage system and the purification of wastewaters. The company serves 9 million residents served in Lazio, Tuscany, Umbria, Molise and Campania; The energy segment manages the transmission and distributesroughly 9 TWh of electricity, public lighting; commercial and trading segment activities include energy management, sale of electricity and gas, energy efficiency for domestic customers. The company is targeting growth in electricity generation from renewable (photovoltaic) sources and in electric mobility, with a view to effectively contributing more and more to the energy transition and decarbonisation. The environment segment provides laboratory, research and related consultancy services on the environment and control functions within the water cycle; engineering services and overseas operations providing water services in Latin America.
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Italy, United States, Germany
Portfolio highlights
- Waxy — Waxy is an innovative startup that operates in the domain of designing, building, and distributing technologies for the sanitization of liquids and food products.
- Tau Group — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
- Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Pre-Seed, Grant
- Italy, United Kingdom
Portfolio highlights
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi:
scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Seed, Pre-Seed, Series A
- Italy, United States
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more
Investment focus
- Nanotechnology, Renewable Energy, Medical Device
- Funding Round, Seed, Pre-Seed
- Italy
Portfolio highlights
- Planckian — Charging the future by powering energy with science We explore frontiers of energy science by developing quantum...
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
- BeDimensional — We produce graphene and others two-dimensional materials (2D) with few atomic layers. Find out more.
NextEnergy Capital is an investment management business founded in 2007, Their head office are in London, United Kingdom. NextEnergy Capital focus on the renewable energy sector with a presence in Italy and South Africa. NextEnergy Capital believes in the sustainable energy investment opportunity and plans to selectively add on other businesses.
Show more
Investment focus
- CleanTech, GreenTech, Recycling
- Pre-Seed
- Italy
Portfolio highlights
- BUFAGA — Aiutiamo le aziende a diventare realmente sostenibili attraverso dispositivi smart in grado di rimuovere l'inquinamento e di raccogliere ed analizzare dati.
We are a venture incubator that wants to exploit the extraordinary human capital of the new digital entrepreneurship. From design to ready-to-market, up looking for new partners and capital, we create value along the entire continuum of mentoring: direct investment , skills qualified and specialized network support the growth of new businesses oftomorrow. With our deal flow , we are able to select innovative ideas with high potential with a business model that minimizes the investment risk and guarantee the success on the market.
Show more
Investment focus
- Internet, Apps, E-Commerce
- Seed, Pre-Seed, Series A
- Italy, United States, Philippines
Portfolio highlights
- Pixies — Pixies is a Startup that design solutions for Autonomous Cities and a more sustainable future of our planet. Merging Urban Design, Robotics and AI, we believe that urban spaces can now become able to take care of themselves.
- Alokino Gelato — Alokino Gelato produces plant-based and preservative-less artisanal ice creams.
- Nimai Digital Company — Think. Create. Make it happen.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more
Investment focus
- Health Care, E-Commerce, Information Technology
- Seed, Series A, Series B
- Italy, Switzerland, United Kingdom
Portfolio highlights
- Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
- Stema — It serves as a platform for hiring engineers
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more
Investment focus
- Biotechnology, Software, Information Technology
- Seed, Series A, Funding Round
- Italy, United Kingdom, France
Portfolio highlights
- Evoralis — Utilise Our Innovative Enzymes to Efficiently Recycle Plastics Into High-Quality Raw Materials
- MicroLub — MicroLub produces a fat replacement for lower-calorie plant-based diets. It is cutting-edge innovation to the next generation of protein technology, creating exclusive ingredient solutions that significantly minimize molecular friction.
- Composite Research — CoRe Research is an start-up, aimed at the study of new product and process solutions in the field of composite materials.
Novum Capital Partners is a Swiss multi-family office.
Show more
Investment focus
- Energy, CleanTech, Smart Cities
- Seed, Series B
- Italy
Portfolio highlights
- Wiseair — Wiseair's mission is to enable everyone in the world to breathe clean air. We believe that a problem you can't measure is a problem you can't solve, so we work to enable municipalities, citizens and businesses to measure and learn about air quality, creating actionable, solution-oriented data and information, and generatingawareness.
- Energy Dome — Energy Dome | Groundbreaking Long Duration Energy Storage. Using CO2 against climate change. Our Technology enables to store renewable energy efficiently.
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Ethiopia
Hong Kong
Faroe Islands
France
Ghana
Czech Republic
Hungary
Georgia
Belgium
Finland
Bahrain
Belarus
Belize
Barbados
Lebanon
Mali
Liberia
Malta
Puerto Rico
Tunisia
Uganda
Sierra Leone
Senegal
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Rwanda
Russian Federation
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Liechtenstein
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
Dominican Republic
Malaysia
Azerbaijan
Iraq
Iceland
Bahamas
Namibia
Nigeria
United Arab Emirates
Jamaica
Italy
Honduras
Panama
Bolivia
Isle of Man
Luxembourg
Myanmar
Albania
Mauritius
Pakistan
Nicaragua
Philippines
Lithuania
Bangladesh
Argentina
Grenada
Jordan
Israel
Romania
Jersey
Norway
Morocco
Mexico
Peru
Kuwait
Kenya
Kazakhstan
Cayman Islands
Cambodia
Guatemala
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
VC (Venture Capital) Funds in Italy by industry
Restaurants
Transportation
Financial Services
Food and Beverage
Venture Capital
Cryptocurrency
Education
Finance
Big Data
Payments
Wine And Spirits
Organic Food
Medical
Medical Device
Internet
Social Media
Wellness
Manufacturing
Digital Media
Social Network
Art
Mobile
Music
Android
Blockchain
Local
Construction
Software
Sports
Enterprise Software
Travel
CleanTech
Hospitality
Automotive
InsurTech
Platforms
Recruiting
Biotechnology
FinTech
Enterprise
Health Care
Consumer
Biotech
Energy
EdTech
Climate
Sustainability
Impact
Proptech
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Mobile Apps
Fashion
Social
Retail
Beauty
Web3
B2B
Life Science
Publishing
Real Estate
Media (entertainment)
Agriculture (agtech)
Social Impact
Fitness
Renewable Energy
SaaS
Oil and Gas